Exact Mass: 725.3721278

Exact Mass Matches: 725.3721278

Found 44 metabolites which its exact mass value is equals to given mass value 725.3721278, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Dalargin

2-{2-[2-(2-{2-[2-amino-3-(4-hydroxyphenyl)propanamido]propanamido}acetamido)-3-phenylpropanamido]-4-methylpentanamido}-5-[(diaminomethylidene)amino]pentanoic acid

C35H51N9O8 (725.3860406)


   

2-Deacetylaustrotaxine

2-Deacetylaustrotaxine

C39H51NO12 (725.3411086)


   
   
   

7,9-O-diacetyltaxine A

7,9-O-diacetyltaxine A

C39H51NO12 (725.3411086)


   

14-O-acetyl-8-O-methyl-18-O-2-(2-methyl-4-oxo-4H-quinazoline-3-yl)benzoylcammaconine

14-O-acetyl-8-O-methyl-18-O-2-(2-methyl-4-oxo-4H-quinazoline-3-yl)benzoylcammaconine

C42H51N3O8 (725.3675966000001)


   

Larazotide

2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]acetic acid

C32H55N9O10 (725.407169)


C308 - Immunotherapeutic Agent

   

(D-Ala2)-leucine enkephalin-arg

(D-Ala2)-Leu-Enkephalin-Arg trifluoroacetate salt

C35H51N9O8 (725.3860406)


Dalargin is a potent δ-opioid receptor agonist. Dalargin mitigates Gentamicin (HY-A0276)-induced cell death. Dalargin shows nephroprotective effects on Gentamicin (HY-A0276A)-induced kidney injury. Dalargin shows antiulcer activity[1][2][3]. Dalargin is a potent δ-opioid receptor agonist. Dalargin mitigates Gentamicin (HY-A0276)-induced cell death. Dalargin shows nephroprotective effects on Gentamicin (HY-A0276A)-induced kidney injury. Dalargin shows antiulcer activity[1][2][3].

   

24-demethoxycarbonyl-24-methylstreptovaricin C

24-demethoxycarbonyl-24-methylstreptovaricin C

C39H51NO12 (725.3411086)


   

3,15,27-Triamino-7,19-dihydroxy-10,22,34-trimethyl-31-oxido-1,13,25-trioxa-7,19,31-triazacyclohexatriaconta-9,21,33-triene-2,8,14,20,26,32-hexone

3,15,27-Triamino-7,19-dihydroxy-10,22,34-trimethyl-31-oxido-1,13,25-trioxa-7,19,31-triazacyclohexatriaconta-9,21,33-triene-2,8,14,20,26,32-hexone

C33H53N6O12- (725.3721278)


   

[(2R,3S,4S,5S,6R)-2-[[(1R,3S,9R,10S,13R,15E,17E,19E,21E,23R,25S,26R,27S)-26-carbamoyl-1,3,9,27-tetrahydroxy-10,13-dimethyl-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraen-23-yl]oxy]-3,5-dihydroxy-6-methyloxan-4-yl]azanium

[(2R,3S,4S,5S,6R)-2-[[(1R,3S,9R,10S,13R,15E,17E,19E,21E,23R,25S,26R,27S)-26-carbamoyl-1,3,9,27-tetrahydroxy-10,13-dimethyl-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraen-23-yl]oxy]-3,5-dihydroxy-6-methyloxan-4-yl]azanium

C36H57N2O13+ (725.3860452)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropyl] (7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropyl] (7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoate

C41H60NO8P (725.405633)


   
   
   
   
   
   
   
   
   
   
   
   
   
   

2-{[13-(4-hydroxy-5,6-dimethoxy-3-methylpyridin-2-yl)-3,5,11-trimethyltrideca-2,6,8,11-tetraen-4-yl]oxy}-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

2-{[13-(4-hydroxy-5,6-dimethoxy-3-methylpyridin-2-yl)-3,5,11-trimethyltrideca-2,6,8,11-tetraen-4-yl]oxy}-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C36H55NO14 (725.362237)


   

2'-deacetylaustrotaxine

NA

C39H51NO12 (725.3411086)


{"Ingredient_id": "HBIN005504","Ingredient_name": "2'-deacetylaustrotaxine","Alias": "NA","Ingredient_formula": "C39H51NO12","Ingredient_Smile": "CC1=C2C(=O)C(C3(C(CC(C2(C)C)C(C1OC(=O)C)OC(=O)C)C(=C)C(CC3OC(=O)C)OC(=O)C(C(C4=CC=CC=C4)N(C)C)O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4719","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2'-deacetylaustrotaxines

NA

C39H51NO12 (725.3411086)


{"Ingredient_id": "HBIN005505","Ingredient_name": "2'-deacetylaustrotaxines","Alias": "NA","Ingredient_formula": "C39H51NO12","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "26033","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

blast 1

NA

C36H51N7O9 (725.3748076)


{"Ingredient_id": "HBIN018643","Ingredient_name": "blast 1","Alias": "NA","Ingredient_formula": "C36H51N7O9","Ingredient_Smile": "NA","Ingredient_weight": "725.83","OB_score": "NA","CAS_id": "151898-96-3","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6176","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1r,3s,9r,10s,13r,15e,17e,19e,21e,23r,26r,27s)-23-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,9,27-tetrahydroxy-10,13-dimethyl-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraene-26-carboxylic acid

(1r,3s,9r,10s,13r,15e,17e,19e,21e,23r,26r,27s)-23-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,9,27-tetrahydroxy-10,13-dimethyl-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraene-26-carboxylic acid

C36H55NO14 (725.362237)


   

2,7,10,13-tetrakis(acetyloxy)-8,12,15,15-tetramethyl-9-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-3,11-dien-5-yl 3-(dimethylamino)-2-hydroxy-3-phenylpropanoate

2,7,10,13-tetrakis(acetyloxy)-8,12,15,15-tetramethyl-9-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-3,11-dien-5-yl 3-(dimethylamino)-2-hydroxy-3-phenylpropanoate

C39H51NO12 (725.3411086)


   

2-{[2-(2-{2-[(3-amino-10-chloro-1,2-dihydroxydecylidene)amino]-n-methylpropanamido}-n,4-dimethylpentanamido)-1-hydroxy-4-methylpentylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

2-{[2-(2-{2-[(3-amino-10-chloro-1,2-dihydroxydecylidene)amino]-n-methylpropanamido}-n,4-dimethylpentanamido)-1-hydroxy-4-methylpentylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C36H60ClN5O8 (725.413019)


   

(2r,3r,4s,5s,6r)-2-{[(2e,4r,5r,6e,8e,11e)-13-(4-hydroxy-5,6-dimethoxy-3-methylpyridin-2-yl)-3,5,11-trimethyltrideca-2,6,8,11-tetraen-4-yl]oxy}-6-({[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(2e,4r,5r,6e,8e,11e)-13-(4-hydroxy-5,6-dimethoxy-3-methylpyridin-2-yl)-3,5,11-trimethyltrideca-2,6,8,11-tetraen-4-yl]oxy}-6-({[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C36H55NO14 (725.362237)


   

2-[(2-{[(1-{2-[(3-amino-1,2-dihydroxydecylidene)amino]-3-methylbutanoyl}pyrrolidin-2-yl)(hydroxy)methylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-hydroxyphenyl)propanoic acid

2-[(2-{[(1-{2-[(3-amino-1,2-dihydroxydecylidene)amino]-3-methylbutanoyl}pyrrolidin-2-yl)(hydroxy)methylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-hydroxyphenyl)propanoic acid

C38H55N5O9 (725.399958)


   

(1r,2s,3e,5s,7s,8s,10r,13s)-2,7,10,13-tetrakis(acetyloxy)-8,12,15,15-tetramethyl-9-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-3,11-dien-5-yl (2r,3s)-3-(dimethylamino)-2-hydroxy-3-phenylpropanoate

(1r,2s,3e,5s,7s,8s,10r,13s)-2,7,10,13-tetrakis(acetyloxy)-8,12,15,15-tetramethyl-9-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-3,11-dien-5-yl (2r,3s)-3-(dimethylamino)-2-hydroxy-3-phenylpropanoate

C39H51NO12 (725.3411086)


   

(2r)-2-{[(1s)-1-{[2-(4-{[(2s,3r,4s,5r,6r)-3,4-dihydroxy-5-[(1-hydroxyethylidene)amino]-6-methyloxan-2-yl]oxy}phenyl)ethenyl]-c-hydroxycarbonimidoyl}-2-(1-methylindol-3-yl)ethyl]amino}-3-methyl-n-(2-phenylethyl)butanimidic acid

(2r)-2-{[(1s)-1-{[2-(4-{[(2s,3r,4s,5r,6r)-3,4-dihydroxy-5-[(1-hydroxyethylidene)amino]-6-methyloxan-2-yl]oxy}phenyl)ethenyl]-c-hydroxycarbonimidoyl}-2-(1-methylindol-3-yl)ethyl]amino}-3-methyl-n-(2-phenylethyl)butanimidic acid

C41H51N5O7 (725.3788296)